Literature DB >> 20380256

[Recurrent goitre: our experience].

Pietro Giorgio Calò1, Massimiliano Tuveri, Giuseppe Pisano, Alberto Tatti, Fabio Medas, Marcello Donati, Angelo Nicolosi.   

Abstract

Recurrence after conservative thyroid surgery ranges from 7 to 40%. Risk factors for recurrence are female sex, multiple nodules in the resected lobe and lack of postoperative LT4 therapy. Indications for reoperation are suspected malignancy, recurrent thyrotoxicosis and recurrent uninodular or multinodulare goitre. From 2002 to 2008, 2149 total thyroidectomies were performed. Ninety-two patients had a completion thyroidectomy. The indication was recurrent multinodular goitre in 81, recurrent thyrotoxicosis in 3, and suspected malignancy in 8. Bilateral completion thyroidectomy was performed in 63 cases, lobectomy in 27 cases, removal of a mediastinal recurrence in 1 case and removal of a pyramidal remnant in 1 case. Histological examination revealed papillary cancer in 18 patients and follicular cancer in 1. Mean operative time was 140 minutes (range: 60-260). All patients were submitted to a minimum follow-up of 6 months. Temporary hypoparathyroidism occurred in 36 patients (39.1%) and definitive hypoparathyroidism in 7 patients (7.6%). Transient recurrent laryngeal nerve palsy occurred in 3 cases (3.2%) and permanent nerve palsy in 1 (1.1%). In 3 cases (3.2%) surgical revision of haemostasis was necessary for postoperative haemorrhage. Total thyroidectomy is the treatment of choice in multinodular goitre. In the cases in which reoperation is necessary, the intervention must be performed by an experienced surgeon.

Entities:  

Mesh:

Year:  2009        PMID: 20380256

Source DB:  PubMed          Journal:  Chir Ital        ISSN: 0009-4773


  6 in total

Review 1.  Complications after reoperative thyroid surgery: retrospective evaluation of 152 consecutive cases.

Authors:  Fabio Medas; Massimiliano Tuveri; Gian Luigi Canu; Ernico Erdas; Pietro Giorgio Calò
Journal:  Updates Surg       Date:  2019-04-01

2.  Complications in thyroid resurgery: a single institutional experience on 233 patients from a whole series of 4,752 homogeneously treated patients.

Authors:  M R Pelizzo; M Variolo; C Bernardi; M Izuzquiza; A Piotto; G Grassetto; P M Colletti; I Merante Boschin; D Rubello
Journal:  Endocrine       Date:  2014-03-11       Impact factor: 3.633

3.  Surgery for recurrent goiter: complication rate and role of the thyroid-stimulating hormone-suppressive therapy after the first operation.

Authors:  P Miccoli; G Frustaci; A Fosso; M Miccoli; G Materazzi
Journal:  Langenbecks Arch Surg       Date:  2014-11-29       Impact factor: 3.445

4.  Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.

Authors:  G Calò; E Erdas; F Medas; L Gordini; A Longheu; G Pisano; A Nicolosi
Journal:  G Chir       Date:  2015 Nov-Dec

5.  Identification alone versus intraoperative neuromonitoring of the recurrent laryngeal nerve during thyroid surgery: experience of 2034 consecutive patients.

Authors:  Pietro Giorgio Calò; Giuseppe Pisano; Fabio Medas; Maria Rita Pittau; Luca Gordini; Roberto Demontis; Angelo Nicolosi
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-06-18

6.  Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option?

Authors:  Pietro Giorgio Calò; Fabio Medas; Rosa Santa Cruz; Francesco Podda; Enrico Erdas; Giuseppe Pisano; Angelo Nicolosi
Journal:  BMC Surg       Date:  2014-03-06       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.